Form 4 Filing for Celularity Inc.

This filing details stock transactions by Robert J. Hariri, Chief Executive Officer of Celularity Inc. On April 13, 2026, 3,281 Restricted Stock Units (RSUs) vested, converting into Class A Common Stock. This conversion is a result of a grant received on April 28, 2022, where 25% of 13,123 RSUs vested. The value of the vested RSUs was $0 per share. Additionally, tax withholdings of 1,182 shares were made at a price of $1.28 per share, resulting in a net post-transaction share count for Mr. Hariri of 2,853,553 shares of Class A Common Stock. The filing is an update to previous disclosures and is primarily related to officer transactions.